Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder

Journal of Orthopaedic Surgery and Research

Volumn 10, Issue 1, 2015, Pages

  Saito, Wataru ^a   Uchida, Kentaro ^a   Matsushita, Osamu ^b   Inoue, Gen ^a   Sekiguchi, Hiroyuki ^a   Aikawa, Jun ^a   Fujimaki, Hisako ^a   Takaso, Masashi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Allogenic demineralized bone matrix; Basic fibroblast growth factor; Bone powder; Collagen binding domain; Fracture healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR-KIDNEY DISEASE DOMAIN-COLLAGEN-BINDING DOMAIN FUSION PROTEIN, MOUSE; CARRIER PROTEIN; FIBROBLAST GROWTH FACTOR 2; HYBRID PROTEIN;

ALLOTRANSPLANTATION; ANIMAL; BONE REGENERATION; BONE TRANSPLANTATION; C3H MOUSE; C57BL MOUSE; CALLUS; DISEASE MODEL; DRUG EFFECTS; FEMORAL FRACTURES; PRECLINICAL STUDY; PROCEDURES;

ANIMALS; BONE REGENERATION; BONE TRANSPLANTATION; BONY CALLUS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMORAL FRACTURES; FIBROBLAST GROWTH FACTOR 2; MICE, INBRED C3H; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION, HOMOLOGOUS;

EID: 85019205267     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/s13018-015-0201-0     Document Type: Article

References (29)

1. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84-A:454-64.
2. Heckman JD, Sarasohn-Kahn J. The economics of treating tibia fractures. The cost of delayed unions. Bull Hosp Jt Dis. 1997;56:63-72.
3. Rose FR, Oreffo RO. Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun. 2002;292:1-7.
4. Ludwig SC, Boden SD. Osteoinductive bone graft substitutes for spinal fusion: a basic science summary. Orthop Clin North Am. 1999;30:635-45.
5. Peel SA, Hu ZM, Clokie CM. In search of the ideal bone morphogenetic protein delivery system: in vitro studies on demineralized bone matrix, purified, and recombinant bone morphogenetic protein. J Craniofac Surg. 2003;14:284-91.
6. Tiedeman JJ, Garvin KL, Kile TA, Connolly JF. The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects. Orthopedics. 1995;18:1153-8.
7. Chen B, Lin H, Wang J, Zhao Y, Wang B, Zhao W, et al. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials. 2007;28:1027-35.
8. Kale AA, Di Cesare PE. Osteoinductive agents. Basic science and clinical applications. Am J Orthop (Belle Mead NJ). 1995;24:752-61.
9. Friedlaender GE. OP-1 clinical studies. J Bone Joint Surg Am. 2001;83-A Suppl 1:S160-1.
10. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83-A Suppl 1:S151-8.
11. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-A:2123-34.
12. Kawaguchi H, Oka H, Jingushi S, Izumi T, Fukunaga M, Sato K, et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J Bone Miner Res. 2010;25:2735-43.
13. Kigami R, Sato S, Tsuchiya N, Yoshimakai T, Arai Y, Ito K. FGF-2 angiogenesis in bone regeneration within critical-sized bone defects in rat calvaria. Implant Dent. 2013;22:422-7.
14. Lai RF, Zhou ZY, Chen T. Accelerating bone generation and bone mineralization in the interparietal sutures of rats using an rhBMP-2/ACS composite after rapid expansion. Exp Anim. 2013;62:189-96.
15. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res. 2001;49:532-42.
16. Unger EF, Goncalves L, Epstein SE, Chew EY, Trapnell CB, Cannon III RO, et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol. 2000;85:1414-9.
17. Nishi N, Matsushita O, Yuube K, Miyanaka H, Okabe A, Wada F. Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain. Proc Natl Acad Sci U S A. 1998;95:7018-23.
18. Uchida K, Matsushita O, Naruse K, Mima T, Nishi N, Hattori S, et al. Acceleration of periosteal bone formation by human basic fibroblast growth factor containing a collagen-binding domain from Clostridium histolyticum collagenase. J Biomed Mater Res A. 2014;102:1737-43.
19. Saito W, Uchida K, Ueno M, Matsushita O, Inoue G, Nishi N, et al. Acceleration of bone formation during fracture healing by injectable collagen powder and human basic fibroblast growth factor containing a collagen-binding domain from Clostridium histolyticum collagenase. J Biomed Mater Res A. 2014;102:3049-55.
20. Katano M, Naruse K, Uchida K, Mikuni-Takagaki Y, Takaso M, Itoman M, et al. Low intensity pulsed ultrasound accelerates delayed healing process by reducing the time required for the completion of endochondral ossification in the aged mouse femur fracture model. Exp Anim. 2011;60:385-95.
21. Uchida K, Urabe K, Naruse K, Kozai Y, Onuma K, Mikuni-Takagaki Y, et al. Differential age-related bone architecture changes between female and male STR/Ort mice. Exp Anim. 2012;61:59-66.
22. Tuli SM, Singh AD. The osteoninductive property of decalcified bone matrix. An experimental study. J Bone Joint Surg (Br). 1978;60:116-23.
23. Wittbjer J, Palmer B, Rohlin M, Thorngren KG. Osteogenetic activity in composite grafts of demineralized compact bone and marrow. Clin Orthop Relat Res. 1983. 229-238.
24. Aspenberg P, Thorngren KG, Lohmander LS. Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats. Acta Orthop Scand. 1991;62:481-4.
25. Lu M, Rabie AB. The effect of demineralized intramembranous bone matrix and basic fibroblast growth factor on the healing of allogeneic intramembranous bone grafts in the rabbit. Arch Oral Biol. 2002;47:831-41.
26. Wang L, Huang Y, Pan K, Jiang X, Liu C. Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation. Ann Biomed Eng. 2010;38:77-87.
27. Akita S, Fukui M, Nakagawa H, Fujii T, Akino K. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen. 2004;12:252-9.
28. Su J, Xu H, Sun J, Gong X, Zhao H. Dual delivery of BMP-2 and bFGF from a new nano-composite scaffold, loaded with vascular stents for large-size mandibular defect regeneration. Int J Mol Sci. 2013;14:12714-28.
29. Wang H, Zou Q, Boerman OC, Nijhuis AW, Jansen JA, Li Y, et al. Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. J Control Release. 2013;166:172-81.